Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 9, 2011 - Issue 8
Submit an article Journal homepage
1,375
Views
12
CrossRef citations to date
0
Altmetric
Review

Primary prophylactic human papillomavirus vaccination programs: future perspective on global impact

Julia ML Brotherton National HPV Vaccination Program Register, Victorian Cytology Service Registries, Victorian Cytology Service, PO Box 310, East Melbourne, Victoria 8002, Australia. [email protected]; Discipline of Paediatrics and Child Health, Sydney Medical School, University of Sydney, Sydney, New South Wales 2006, Australia; National HPV Vaccination Program Register, Victorian Cytology Service Registries, Victorian Cytology Service, PO Box 310, East Melbourne, Victoria 8002, Australia. [email protected]; Discipline of Paediatrics and Child Health, Sydney Medical School, University of Sydney, Sydney, New South Wales 2006, Australia
&
Dorota M Gertig Victorian Cervical Cytology Registry, Victorian Cytology Service Registries, Victorian Cytology Service, PO Box 310, East Melbourne, Victoria 8002, Australia; Victorian Cervical Cytology Registry, Victorian Cytology Service Registries, Victorian Cytology Service, PO Box 310, East Melbourne, Victoria 8002, Australia
Pages 627-639 | Published online: 10 Jan 2014

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Anne Szarewski. (2012) Cervarix®: a bivalent vaccine against HPV types 16 and 18, with cross-protection against other high-risk HPV types. Expert Review of Vaccines 11:6, pages 645-657.
Read now

Articles from other publishers (11)

Mingjun Ma, Jingfen Zhu, Yongbin Yang, Xiaoyun Wang, Yubiao Jin, Jiawen Zhang & Sufang Wu. (2022) The distribution and pathogenic risk of non‐9‐valent vaccine covered HPV subtypes in cervical lesions. Cancer Medicine 11:6, pages 1542-1552.
Crossref
Lee Marvin Reyes, Juan León Aguilar, Perla Villamor, Carlos De La Torre, Alicia Álvarez, Edgar Mantilla & Hiram Álvarez-Neri. (2018) Clinical and sociodemographic characteristics associated with disease severity in juvenile recurrent respiratory papillomatosis: A study of 104 patients in a tertiary care pediatric hospital. International Journal of Pediatric Otorhinolaryngology 108, pages 63-66.
Crossref
Xavier Castellsagué, Kevin A. Ault, F. Xavier Bosch, Darron Brown, Jack Cuzick, Daron G. Ferris, Elmar A. Joura, Suzanne M. Garland, Anna R Giuliano, Mauricio Hernandez-Avila, Warner Huh, Ole-Erik Iversen, Susanne K. Kjaer, Joaquin Luna, Joseph Monsonego, Nubia Muñoz, Evan Myers, Jorma Paavonen, Punnee Pitisuttihum, Marc Steben, Cosette M. Wheeler, Gonzalo Perez, Alfred Saah, Alain Luxembourg, Heather L Sings & Christine Velicer. (2016) Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region. Papillomavirus Research 2, pages 61-69.
Crossref
Paolo Bonanni, Angela Bechini, Rosa Donato, Raffaella Capei, Cristiana Sacco, Miriam Levi & Sara Boccalini. (2014) Human papilloma virus vaccination: impact and recommendations across the world. Therapeutic Advances in Vaccines 3:1, pages 3-12.
Crossref
Beatriz Serrano, Laia Alemany, Patricia Alonso de Ruiz, Sara Tous, Marcus Aurelho Lima, Laia Bruni, Asha Jain, Gary M. Clifford, You Lin Qiao, Thomas Weiss, F Xavier Bosch & Silvia de Sanjosé. (2014) Potential impact of a 9-valent HPV vaccine in HPV-related cervical disease in 4 emerging countries (Brazil, Mexico, India and China). Cancer Epidemiology 38:6, pages 748-756.
Crossref
Nora Berois, Patricia De Cremoux, Daniel Mazal, Adela Sica, Mabel Cedeira, Benedicta Caserta, Enrique Barrios, Eduardo Osinaga & Xavier Sastre-Garau. (2013) Prevalence and Distribution of High-Risk Human Papillomavirus Genotypes in Invasive Carcinoma of the Uterine Cervix in Uruguay. International Journal of Gynecologic Cancer 23:3, pages 527-532.
Crossref
Ning-Chia Chang. (2013) Squamous papilloma in the external auditory canal: A common lesion in an uncommon site. World Journal of Clinical Cases 1:2, pages 92.
Crossref
Beatriz Serrano, Laia Alemany, Sara Tous, Laia Bruni, Gary M Clifford, Thomas Weiss, Francesc Xavier Bosch & Silvia de Sanjosé. (2012) Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease. Infectious Agents and Cancer 7:1.
Crossref
M. Poljak. (2012) Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges. Clinical Microbiology and Infection 18, pages 64-69.
Crossref
LIVIO GARATTINI & KATELIJNE VAN DE VOOREN. (2012) HPV Vaccination for Boys? Talking Economic Sense. The Journal of Sexual Medicine 9:8, pages 2195-2196.
Crossref
Manuel Rodríguez-Iglesias. (2012) Diagnóstico molecular del papilomavirus humano: nuevos desafíos en un escenario diferente. Enfermedades Infecciosas y Microbiología Clínica 30:5, pages 223-224.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.